Phoenix WinNonlin Workflows: Estimate Pre-clinical PK/PD Parameters for Anti-Cancer Agents

Are you utilizing Phoenix WinNonlin to effectively evaluate the safety, efficacy and target specificity of investigational drugs? Are you building workflows from scratch for every new drug compound? Learn how to use Phoenix templates to accelerate characterizing a drug’s PK/PD profile. In this webinar, Certara’s Dr. Bernd Wendt demonstrated how Phoenix WinNonlin has been used to rank anti-cancer compounds according to their efficacy to ultimately select which to promote to clinical development.

Learn More LinkedIn Twitter Facebook Email